What is Sensus Healthcare Inc's earnings per share (EPS)?

Sensus Healthcare Inc (SRTS) reported diluted earnings per share of $-0.47 for fiscal year 2025. This represents a -214.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sensus Healthcare Inc Financials

SRTS

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Sensus Healthcare Inc (SRTS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 38/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Sensus Healthcare Inc has an operating margin of -37.5%, meaning the company retains $-38 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 19.4% the prior year.

Growth

Sensus Healthcare Inc's revenue declined 34.3% year-over-year, from $41.8M to $27.5M. This contraction results in a growth score of 0/100.

Leverage

100

Sensus Healthcare Inc carries a low D/E ratio of 0.10, meaning only $0.10 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 9.72, Sensus Healthcare Inc holds $9.72 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

Sensus Healthcare Inc's free cash flow margin of 1.2% results in a low score of 28/100. Capital expenditures of $196K absorb a large share of operating cash flow.

Returns

Sensus Healthcare Inc generates a -16.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 11.9% the prior year.

Piotroski F-Score Neutral

4/9

Sensus Healthcare Inc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

-0.07x

For every $1 of reported earnings, Sensus Healthcare Inc generates $-0.07 in operating cash flow ($528K OCF vs -$7.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-15.1x

Sensus Healthcare Inc earns $-15.1 in operating income for every $1 of interest expense (-$10.3M vs $683K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$27.5M

YoY-34.3%

5Y CAGR+23.5%

10Y CAGR+10.3%

Sensus Healthcare Inc generated $27.5M in revenue in fiscal year 2025. This represents a decrease of 34.3% from the prior year.

EBITDA

-$9.9M

YoY-219.5%

Sensus Healthcare Inc's EBITDA was -$9.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 219.5% from the prior year.

Net Income

-$7.7M

YoY-216.1%

Sensus Healthcare Inc reported -$7.7M in net income in fiscal year 2025. This represents a decrease of 216.1% from the prior year.

EPS (Diluted)

$-0.47

YoY-214.6%

Sensus Healthcare Inc earned $-0.47 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 214.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$332K

YoY+130.0%

Sensus Healthcare Inc generated $332K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 130.0% from the prior year.

Cash & Debt

$22.1M

YoY+0.1%

5Y CAGR+8.2%

10Y CAGR+15.9%

Sensus Healthcare Inc held $22.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

16M

YoY-0.2%

5Y CAGR-0.0%

10Y CAGR+4.7%

Sensus Healthcare Inc had 16M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Margins & Returns

Gross Margin

43.2%

YoY-15.3pp

5Y CAGR-11.6pp

10Y CAGR-20.9pp

Sensus Healthcare Inc's gross margin was 43.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 15.3 percentage points from the prior year.

Operating Margin

-37.5%

YoY-56.9pp

5Y CAGR+48.5pp

10Y CAGR-35.4pp

Sensus Healthcare Inc's operating margin was -37.5% in fiscal year 2025, reflecting core business profitability. This is down 56.9 percentage points from the prior year.

Net Margin

-28.1%

YoY-44.0pp

5Y CAGR+43.3pp

10Y CAGR-25.8pp

Sensus Healthcare Inc's net profit margin was -28.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 44.0 percentage points from the prior year.

Return on Equity

-16.1%

YoY-28.0pp

5Y CAGR+15.8pp

10Y CAGR-12.0pp

Sensus Healthcare Inc's ROE was -16.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 28.0 percentage points from the prior year.

Capital Allocation

R&D Spending

$7.8M

YoY+84.5%

5Y CAGR+13.3%

10Y CAGR+18.2%

Sensus Healthcare Inc invested $7.8M in research and development in fiscal year 2025. This represents an increase of 84.5% from the prior year.

Share Buybacks

$300K

Sensus Healthcare Inc spent $300K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$196K

YoY-29.0%

5Y CAGR-11.4%

10Y CAGR-0.0%

Sensus Healthcare Inc invested $196K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 29.0% from the prior year.

SRTS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$27.5M-34.3%	$41.8M+71.3%	$24.4M-45.2%	$44.5M+64.7%	$27.0M+182.4%	$9.6M
Cost of Revenue	$15.6M-10.1%	$17.4M+68.0%	$10.3M-30.6%	$14.9M+48.2%	$10.1M+132.3%	$4.3M
Gross Profit	$11.9M-51.4%	$24.4M+73.8%	$14.1M-52.5%	$29.6M+74.4%	$17.0M+223.6%	$5.2M
R&D Expenses	$7.8M+84.5%	$4.2M+14.6%	$3.7M+6.3%	$3.5M+0.7%	$3.4M-17.4%	$4.2M
SG&A Expenses	$7.9M+10.2%	$7.1M+38.6%	$5.2M+3.0%	$5.0M+9.0%	$4.6M+15.2%	$4.0M
Operating Income	-$10.3M-227.4%	$8.1M+2217.8%	-$382K-102.6%	$14.8M+260.0%	$4.1M+150.0%	-$8.2M
Interest Expense	$683K+173.3%	-$932K+6.0%	-$992K-161.1%	-$380K-19100.0%	$2K-85.7%	$14K
Income Tax	-$1.9M-180.2%	$2.4M+1322.2%	$167K-95.5%	$3.7M	N/A	N/A
Net Income	-$7.7M-216.1%	$6.6M+1270.5%	$485K-98.0%	$24.2M+488.6%	$4.1M+160.3%	-$6.8M
EPS (Diluted)	$-0.47-214.6%	$0.41+1266.7%	$0.03-97.9%	$1.46+484.0%	$0.25+159.5%	$-0.42

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$4.9M-28.3%	$6.9M-5.9%	$7.3M-12.3%	$8.3M-36.1%	$13.1M+47.8%	$8.8M-4.3%	$9.2M-13.4%	$10.7M
Cost of Revenue	$3.0M-27.1%	$4.2M-5.5%	$4.4M+10.6%	$4.0M-33.1%	$6.0M+65.6%	$3.6M-5.7%	$3.8M-4.6%	$4.0M
Gross Profit	$1.9M-30.1%	$2.7M-6.5%	$2.9M-33.3%	$4.4M-38.7%	$7.1M+35.6%	$5.2M-3.4%	$5.4M-18.6%	$6.7M
R&D Expenses	$1.9M+3.5%	$1.8M+23.7%	$1.5M-43.6%	$2.6M+66.9%	$1.6M+80.9%	$863K-0.3%	$866K-6.5%	$926K
SG&A Expenses	$1.8M-8.1%	$1.9M-3.5%	$2.0M-10.1%	$2.2M-8.6%	$2.4M+53.6%	$1.6M-0.4%	$1.6M0.0%	$1.6M
Operating Income	-$3.1M-22.6%	-$2.6M-32.2%	-$1.9M+26.6%	-$2.6M-253.3%	$1.7M+15.5%	$1.5M-24.6%	$2.0M-31.3%	$2.9M
Interest Expense	$890K+456.3%	$160K+187.4%	-$183K+0.5%	-$184K+76.6%	-$788K-382.4%	$279K+233.5%	-$209K+2.3%	-$214K
Income Tax	$174K+111.9%	-$1.5M-102.8%	-$723K-757.3%	$110K-73.2%	$410K-26.7%	$559K-3.5%	$579K-30.0%	$827K
Net Income	-$3.2M-235.8%	-$943K+9.1%	-$1.0M+59.7%	-$2.6M-266.4%	$1.5M+27.2%	$1.2M-24.6%	$1.6M-29.1%	$2.3M
EPS (Diluted)	N/A	$-0.060.0%	$-0.06+62.5%	$-0.16	N/A	$0.07-30.0%	$0.10-28.6%	$0.14

SRTS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$53.0M-14.7%	$62.2M+15.7%	$53.7M-5.3%	$56.7M+76.0%	$32.2M+15.1%	$28.0M
Current Assets	$45.9M-19.1%	$56.7M+14.6%	$49.5M-7.0%	$53.2M+70.4%	$31.2M+24.1%	$25.2M
Cash & Equivalents	$22.1M+0.1%	$22.1M-4.7%	$23.1M-9.3%	$25.5M+75.8%	$14.5M-2.6%	$14.9M
Inventory	$14.6M+44.2%	$10.1M-14.9%	$11.9M+238.8%	$3.5M+99.0%	$1.8M-60.3%	$4.4M
Accounts Receivable	$6.0M-69.4%	$19.7M+85.4%	$10.6M-38.5%	$17.3M+42.6%	$12.1M+221.2%	$3.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.9M-22.0%	$6.3M+30.2%	$4.9M-43.8%	$8.7M+39.2%	$6.2M-4.4%	$6.5M
Current Liabilities	$4.7M-19.8%	$5.9M+39.7%	$4.2M-45.3%	$7.7M+29.1%	$6.0M+22.8%	$4.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$48.1M-13.8%	$55.8M+14.3%	$48.8M+1.6%	$48.1M+84.8%	$26.0M+21.0%	$21.5M
Retained Earnings	$5.7M-57.5%	$13.4M+97.9%	$6.8M+7.7%	$6.3M+135.1%	-$17.9M+18.7%	-$22.1M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$53.0M-9.0%	$58.3M-0.9%	$58.9M-2.3%	$60.2M-3.1%	$62.2M+3.9%	$59.9M+2.9%	$58.2M+1.6%	$57.3M
Current Assets	$45.9M-8.6%	$50.2M-3.9%	$52.2M-3.6%	$54.2M-4.5%	$56.7M+3.5%	$54.8M+0.6%	$54.5M+1.0%	$53.9M
Cash & Equivalents	$22.1M-9.7%	$24.5M+10.3%	$22.2M+16.2%	$19.1M-13.5%	$22.1M-2.2%	$22.6M+18.9%	$19.0M+28.8%	$14.7M
Inventory	$14.6M+11.7%	$13.0M+5.1%	$12.4M+25.0%	$9.9M-1.7%	$10.1M-15.6%	$12.0M-6.3%	$12.8M-13.3%	$14.7M
Accounts Receivable	$6.0M-35.3%	$9.3M-26.0%	$12.6M-29.9%	$18.0M-8.7%	$19.7M+16.3%	$17.0M-7.3%	$18.3M-6.8%	$19.6M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.9M-30.4%	$7.1M+4.6%	$6.8M-5.4%	$7.2M+13.2%	$6.3M+10.7%	$5.7M+8.8%	$5.3M-13.3%	$6.1M
Current Liabilities	$4.7M-30.6%	$6.8M+6.1%	$6.4M-4.6%	$6.7M+14.3%	$5.9M+13.0%	$5.2M+11.3%	$4.7M-14.5%	$5.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$48.1M-6.0%	$51.2M-1.7%	$52.1M-1.8%	$53.0M-5.0%	$55.8M+3.1%	$54.1M+2.3%	$52.9M+3.3%	$51.2M
Retained Earnings	$5.7M-35.7%	$8.9M-9.6%	$9.8M-9.5%	$10.9M-19.1%	$13.4M+13.0%	$11.9M+11.4%	$10.7M+17.8%	$9.1M

SRTS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$528K+163.5%	-$831K+61.3%	-$2.1M-51.9%	-$1.4M-393.7%	-$286K+34.1%	-$434K
Capital Expenditures	$196K-29.0%	$276K+20.5%	$229K+44.0%	$159K+24.2%	$128K-64.3%	$359K
Free Cash Flow	$332K+130.0%	-$1.1M+53.4%	-$2.4M-51.1%	-$1.6M-279.5%	-$414K+47.8%	-$793K
Investing Cash Flow	-$196K+29.0%	-$276K-47.6%	-$187K-101.3%	$14.8M+11404.7%	$129K-98.2%	$7.0M
Financing Cash Flow	-$305K-2133.3%	$15K+137.5%	-$40K+98.4%	-$2.4M-951.1%	-$231K-209.5%	$211K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$300K	N/A	$27K-99.1%	$3.0M	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$2.2M-196.2%	$2.3M-26.4%	$3.1M+216.4%	-$2.7M-223.7%	-$827K-120.9%	$4.0M-6.5%	$4.2M+151.7%	-$8.2M
Capital Expenditures	$158K+3850.0%	$4K-85.2%	$27K+285.7%	$7K+102.4%	-$297K-188.1%	$337K+11133.3%	$3K-98.7%	$233K
Free Cash Flow	-$2.4M-203.2%	$2.3M-25.9%	$3.1M+215.1%	-$2.7M-138.8%	-$1.1M-131.1%	$3.6M-14.5%	$4.2M+150.2%	-$8.4M
Investing Cash Flow	-$158K-3850.0%	-$4K+85.2%	-$27K-285.7%	-$7K-102.4%	$297K+188.1%	-$337K-11133.3%	-$3K+98.7%	-$233K
Financing Cash Flow	-$5K	$0	$0+100.0%	-$300K-1171.4%	$28K+193.3%	-$30K	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0	$0-100.0%	$300K	N/A	N/A	N/A	N/A

SRTS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	43.2%-15.3pp	58.4%+0.8pp	57.6%-8.9pp	66.5%+3.7pp	62.8%+8.0pp	54.8%
Operating Margin	-37.5%-56.9pp	19.4%+20.9pp	-1.6%-34.9pp	33.3%+18.1pp	15.2%+101.2pp	-86.0%
Net Margin	-28.1%-44.0pp	15.9%+13.9pp	2.0%-52.4pp	54.4%+39.2pp	15.2%+86.6pp	-71.4%
Return on Equity	-16.1%-28.0pp	11.9%+10.9pp	1.0%-49.4pp	50.4%+34.6pp	15.8%+47.6pp	-31.8%
Return on Assets	-14.5%-25.2pp	10.7%+9.8pp	0.9%-41.8pp	42.7%+29.9pp	12.8%+37.2pp	-24.4%
Current Ratio	9.72+0.1	9.64-2.1	11.76+4.8	6.92+1.7	5.24+0.1	5.18
Debt-to-Equity	0.10-0.0	0.11+0.0	0.10-0.1	0.18-0.1	0.24-0.1	0.30
FCF Margin	1.2%+3.9pp	-2.6%+7.1pp	-9.7%-6.2pp	-3.5%-2.0pp	-1.5%+6.8pp	-8.3%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	38.4%-1.0pp	39.4%-0.3pp	39.7%-12.5pp	52.2%-2.2pp	54.4%-4.9pp	59.3%+0.6pp	58.7%-3.8pp	62.5%
Operating Margin	-63.8%-26.4pp	-37.3%-10.8pp	-26.6%+5.1pp	-31.7%-44.9pp	13.2%-3.7pp	16.9%-4.5pp	21.4%-5.6pp	27.1%
Net Margin	-64.1%-50.4pp	-13.7%+0.5pp	-14.2%+16.6pp	-30.8%-42.6pp	11.8%-1.9pp	13.8%-3.7pp	17.4%-3.9pp	21.3%
Return on Equity	-6.6%-4.7pp	-1.8%+0.2pp	-2.0%+2.9pp	-4.9%-7.6pp	2.8%+0.5pp	2.2%-0.8pp	3.0%-1.4pp	4.4%
Return on Assets	-6.0%-4.4pp	-1.6%+0.1pp	-1.8%+2.5pp	-4.3%-6.8pp	2.5%+0.5pp	2.0%-0.7pp	2.8%-1.2pp	4.0%
Current Ratio	9.72+2.3	7.38-0.8	8.14+0.1	8.06-1.6	9.64-0.9	10.52-1.1	11.63+1.8	9.85
Debt-to-Equity	0.10-0.0	0.140.0	0.130.0	0.14+0.0	0.110.0	0.110.0	0.10-0.0	0.12
FCF Margin	-47.9%-81.2pp	33.3%-9.0pp	42.2%+74.4pp	-32.2%-23.6pp	-8.6%-49.5pp	40.9%-4.8pp	45.8%+124.7pp	-79.0%

Similar Companies

WORK Medical Technology Group LTD WOK

$1.4M

Elutia Inc. ELUT

$48.3M

Spectral AI Inc. MDAI

$53.1M

Tela Bio, Inc. TELA

$26.6M

Cytosorbents Corp CTSO

$37.9M

Frequently Asked Questions

What is Sensus Healthcare Inc's annual revenue?

Sensus Healthcare Inc (SRTS) reported $27.5M in total revenue for fiscal year 2025. This represents a -34.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sensus Healthcare Inc's revenue growing?

Sensus Healthcare Inc (SRTS) revenue declined by 34.3% year-over-year, from $41.8M to $27.5M in fiscal year 2025.

Is Sensus Healthcare Inc profitable?

No, Sensus Healthcare Inc (SRTS) reported a net income of -$7.7M in fiscal year 2025, with a net profit margin of -28.1%.

What is Sensus Healthcare Inc's EBITDA?

Sensus Healthcare Inc (SRTS) had EBITDA of -$9.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Sensus Healthcare Inc's gross margin?

Sensus Healthcare Inc (SRTS) had a gross margin of 43.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Sensus Healthcare Inc's operating margin?

Sensus Healthcare Inc (SRTS) had an operating margin of -37.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Sensus Healthcare Inc's net profit margin?

Sensus Healthcare Inc (SRTS) had a net profit margin of -28.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Sensus Healthcare Inc's return on equity (ROE)?

Sensus Healthcare Inc (SRTS) has a return on equity of -16.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Sensus Healthcare Inc's free cash flow?

Sensus Healthcare Inc (SRTS) generated $332K in free cash flow during fiscal year 2025. This represents a 130.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Sensus Healthcare Inc's operating cash flow?

Sensus Healthcare Inc (SRTS) generated $528K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Sensus Healthcare Inc's total assets?

Sensus Healthcare Inc (SRTS) had $53.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Sensus Healthcare Inc's capital expenditures?

Sensus Healthcare Inc (SRTS) invested $196K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Sensus Healthcare Inc spend on research and development?

Sensus Healthcare Inc (SRTS) invested $7.8M in research and development during fiscal year 2025.

Does Sensus Healthcare Inc buy back shares?

Yes, Sensus Healthcare Inc (SRTS) spent $300K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Sensus Healthcare Inc have outstanding?

Sensus Healthcare Inc (SRTS) had 16M shares outstanding as of fiscal year 2025.

What is Sensus Healthcare Inc's current ratio?

Sensus Healthcare Inc (SRTS) had a current ratio of 9.72 as of fiscal year 2025, which is generally considered healthy.

What is Sensus Healthcare Inc's debt-to-equity ratio?

Sensus Healthcare Inc (SRTS) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Sensus Healthcare Inc's return on assets (ROA)?

Sensus Healthcare Inc (SRTS) had a return on assets of -14.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Sensus Healthcare Inc's Piotroski F-Score?

Sensus Healthcare Inc (SRTS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Sensus Healthcare Inc's earnings high quality?

Sensus Healthcare Inc (SRTS) has an earnings quality ratio of -0.07x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Sensus Healthcare Inc cover its interest payments?

Sensus Healthcare Inc (SRTS) has an interest coverage ratio of -15.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Sensus Healthcare Inc?

Sensus Healthcare Inc (SRTS) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.